News

Top news of the week from Specialty Pharmacy Times.
Despite the benefits of oral oncolytics, high out-of-pocket costs could put treatment out of reach for patients with cancer.
A small number of liquid biopsy test results from different providers matched for overlapping genetic sequences.
Treatment with upadacitinib resulted in reduced disease activity and clinical remission in patients with rheumatoid arthritis.
Providing information about breast cancer surgery via an online tool may help patients feel more informed about their treatment options.
Top news of the day from across the health care landscape.
Promacta is a bone marrow stimulant previously approved by the FDA to treat adults and children with chronic immune thrombocytopenia.

Most Popular

Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2017
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.
 

$vacMongoViewPlus$